REQUEST A DEMO
Total
USD $0.00
Search more companies

Shanghai Bio-heart Biological Technology Company Limited (China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Shanghai Bio-heart Biological Technology Company Limited Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shanghai Bio-heart Biological Technology Company Limited is a company located in Shanghai, China. The company was incorporated on August 31, 1999. It was established by Pan Weiguo, Wei Peitian, and Nantong Guosheng Precision Sheet Metal Factory. The registered capital at the time of establishment was 1.2 million yuan, with Pan Weiguo contributing 813,600 yuan, Wei Peitian contributing 60,000 yuan, and Nantong Guosheng Precision Sheet Metal Factory contributing 326,400 yuan. On August 25, 1999, Nantong Gangzha Audit Office issued a capital verification report, confirming that the shareholders had completed the registered capital payment. On August 31, 1999, Shanghai Bio-heart obtained the Enterprise Legal Person Business License issued by the Nantong Administration for Industry and Commerce. The company was restructured and established by Nantong Guosheng Electromechanical Group Co., Ltd. on August 2, 2016. On June 18, 2016, Shanghai Bio-heart held a temporary shareholders' meeting, where it was decided that Pan Weiguo and Wei Xiaohu, the original shareholders of Shanghai Bio-heart, would establish a joint-stock company through restructuring, and the company would be renamed Nantong Guosheng Intelligent Technology Group Co., Ltd. According to the audit report issued by Tianheng Accounting Firm on May 20, 2016, based on the audited net assets of Shanghai Bio-heart as of March 31, 2016, which amounted to 209.6038 million yuan, 638 million yuan was included in the company's capital stock, 2.5742 million yuan was included in the company's special reserves, and 1,432.296 million yuan was included in the company's capital surplus. On the same day, Pan Weiguo and Wei Xiaohu, the original shareholders of Shanghai Bio-heart, signed a Founder Agreement to establish Guosheng Intelligence. On May 30, 2016, Wanheng Evaluation issued an evaluation report with a valuation date of March 31, 2016, stating that the net asset book value of Shanghai Bio-heart was 209.6038 million yuan, the assessed value was 350.8241 million yuan, the value-added was 141.2203 million yuan, and the value-added rate was 67.37%. On July 28, 2016, Tianheng Accounting Firm issued a capital verification report, verifying the aforementioned changes. On August 2, 2016, Shanghai Bio-heart completed the business registration procedures at the Nantong Administration for Industry and Commerce and obtained the Business License with a unified social credit code of 9132060071496854X3.

Headquarters
Room 302, 3/F, Building 4, No.590 Ruiqing Road, East Zhangjiang Hi-Tech Park, Pudong New Area
Shanghai; Shanghai;

Contact Details: Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.

Website: http://www.bio-heart.com

Basic Information
Total Employees:
Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.
Outstanding Shares:
Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.
Registered Capital:
Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.
Financial Auditors:
Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.
Incorporation Date:
July 01, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
22.43%
Subsidiaries
Hong Kong Bio-Heart Biological Technology Co., Limited (Hong Kong SAR, China)
100%
Shanghai Angiocare Medical Technology Co., Ltd.
65.69%
Company Performance
Financial values in the chart are available after Shanghai Bio-heart Biological Technology Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
14.9%
EBITDA
30.65%
Net Profit (Loss) for the Period
18.21%
Total assets
-16.67%
Total equity
-15.43%
Return on Equity (ROE)
0.83%
Debt to Equity Ratio
-1.75%
Quick Ratio
1.38%
Cash Ratio
2.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?